Researchers discovered a mechanism that stops the body reacting with an excessive immune reaction. This could be the basis for a new treatment.
Most people with allergies have to take medication throughout their life: Their body “thinks” that proteins from the environment are so “strange” that they elicit an immune reaction. Until present, it was not possible to develop an efficient therapy so that the body “learns” to stop in an overreacting way.
Scientists from the Swiss Institute of Allergy and Asthma Research (SIAF) in Davos, from the University of Tokyo, the RIKEN Research Institute in Yokohoma, and from Stanford University recently discovered a mechanism that could be the basis for a new way to handle allergies.
Mast cells play a key role in the disease process in allergies: As a reaction towards an allergen – for example pollen or dust mites – they release big amounts of substances that initiate an inflammatory process. Study leader Hideaki Morita and his team discovered that mast cells are not only “bad guys”, but also have a “good side” (see figure): They release the substance interleukin-2 that induces the production of certain immune cells called T-regulatory (Treg) cells. Treg cells can suppress the allergic inflammatory process in the airways induced by interleukin-10.
It is already known for some time that Treg cells can subdue an excessive immune response and the resulting inflammation. For example, injections with Treg cells prevented autoimmune diseases in mice. However, for Treg cell treatments one needs a large amount of these cells, which is not easy to realise. In the blood, there are just a few of them, and in vitro they are difficult to produce. Using mast cells, Treg cells could be easily produced in the laboratory in large quantities.
“The mechanism that we discovered, could be the basis for a new way to handle allergies,” says Hideaki Morita.
Read more: A possible cure for allergies
The Latest on: Cure for allergies
via Google News
The Latest on: Cure for allergies
- Akeso is Rapidly Advancing The Phase II Clinical Trial of IL-4R Monoclonal Antibody (AK120) for the Treatment of Atopic Dermatitis and Asthmaon October 14, 2021 at 9:44 pm
Akeso, Inc. (the Company, 9926.HK) announces that the Company's self-developed innovative drug candidate, IL-4R monoclonal antibody (AK120), was approved by the Center for Drug Evaluation (CDE) of the ...
- 🌱 New Clinic For Food Allergies + Netflix To Expand ABQ Studioon October 13, 2021 at 4:08 pm
Patients who are being seen for food allergies have the opportunity to undergo oral immunotherapy treatment (OIT) in Albuquerque. OIT is the process of re-training the immune system to recognize the ...
- FDA Approves Dextenza for Use in Patients With Ocular Itching Associated With Allergic Conjunctivitison October 13, 2021 at 9:18 am
According to Ocular Therapeutix, Dextenza is now the first FDA-approved, physician-administered intracanalicular insert capable of delivering a preservative-free drug for the treatment of ocular ...
- KRQE Newsfeed: Building closed, Child found safe, Staying cool, Water access, Allergy treatmenton October 13, 2021 at 5:26 am
Wednesday’s Top Stories Man charged for deadly 2017 crash on I-25 near San AntonioAPD investigates video showing shots fired from car window‘I want answers and accountability’: School gym ...
- Life-saving food allergy treatment comes to Albuquerqueon October 12, 2021 at 9:10 pm
There’s some good news for people with life-threatening food allergies in New Mexico. Patients who are being seen for food allergies have the opportunity to ...
- Global Peanut Allergy Treatment Market Insights by Industry Demand, Regional Share Analysis and Forecast 2021-2027on October 11, 2021 at 2:46 pm
MarketsandResearch.biz offers a newly added report titled Global Peanut Allergy Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2027 from its repertoire on the global ...
- Ocular Therapeutix™ Announces FDA Approval of Supplemental New Drug Application (sNDA) for DEXTENZA® (dexamethasone ophthalmic insert) 0.4 mg for Intracanalicular Use for ...on October 11, 2021 at 1:30 pm
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative thera ...
- This Clever Dock Self-Empties My Robot Vacuum for Me—and It's the Best Cure for My Allergieson October 7, 2021 at 9:11 am
Despite owning a robot vacuum for years, I've never quite gotten over the futuristic feeling of having a tiny robot in my house cleaning my floors. If I'm being honest, the time-saving device does ...
- 8 Home Remedies for Allergy Relief That Really Work—and 3 That Don't, According to Expertson October 1, 2021 at 6:43 am
Experts share home remedies for allergy relief that work. These research-backed natural remedies should help alleviate your most annoying allergy symptoms.
- Home Remedies for Allergy Symptoms That Really Work, According to Expertson October 1, 2021 at 6:43 am
Get some relief with these natural solutions. When you have bad allergies, it can feel like there’s no way to escape them, and allergies are not just a problem for a few weeks in the spring. Fall can ...
via Bing News